The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2
Mark N. Adams(Queensland University of Technology), John D. Hooper(Mater Research)
Cited by 52
Related Papers
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer
|Journal of Thoracic Oncology|2017|84
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
|British Journal of Cancer|2016|82
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
|Theranostics|2020|31
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
|Communications Biology|2021|26